F. Guillemin, A. Saraux, P. Guggenbuhl, C. Roux, P. Fardellone et al., Prevalence of rheumatoid arthritis in France, Ann. Rheum. Dis. oct, vol.64, issue.10, p.14271430, 2001.

A. Saraux, F. Guillemin, P. Guggenbuhl, C. Roux, P. Fardellone et al., Prevalence of spondyloarthropathies in France, Ann. Rheum. Dis. oct, vol.64, issue.10, p.14311435, 2001.

B. Fautrel, Epidemiology and impact of rheumatoid arthritis, la lettre du rhumatologue, 2006.

D. Huscher, S. Merkesdal, K. Thiele, H. Zeidler, M. Schneider et al., Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany, Annals of the Rheumatic Diseases, vol.65, issue.9, pp.1175-1183, 2006.
DOI : 10.1136/ard.2005.046367

W. Mau, J. Listing, D. Huscher, H. Zeidler, and A. Zink, Employment across chronic inflammatory rheumatic diseases and comparison with the general population, The Journal of Rheumatology, vol.32, issue.4, pp.721-728, 2005.

J. Smolen, D. Aletaha, and J. Bijlsma, Treating rheumatoid arthritis to target: recommendations of an international task force, Annals of the Rheumatic Diseases, vol.69, issue.4, pp.631-671, 2010.
DOI : 10.1136/ard.2009.123919

J. Nam, K. Winthrop, V. Vollenhoven, and R. , Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.976-86, 2010.
DOI : 10.1136/ard.2009.126573

J. Smolen, R. Landewé, and F. Breedveld, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.964-75, 2010.
DOI : 10.1136/ard.2009.126532

URL : https://hal.archives-ouvertes.fr/hal-01778213

I. Nahar, K. Shojania, C. Marra, A. Alamgir, and A. Anis, Infliximab treatment of rheumatoid arthritis and Crohn's disease. Ann Pharmacother, pp.1256-65, 2003.

A. Alldred, Etanercept in rheumatoid arthritis, Expert Opinion on Pharmacotherapy, vol.63, issue.8, pp.1137-1185, 2001.
DOI : 10.1093/rheumatology/35.8.781

L. Bang and G. Keating, Adalimumab, BioDrugs, vol.16, issue.2, pp.121-160, 2004.
DOI : 10.2165/00063030-200418020-00005

R. Fleischmann, J. Schechtman, R. Bennett, M. Handel, G. Burmester et al., Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial, Arthritis & Rheumatism, vol.48, issue.4, pp.927-961, 2003.
DOI : 10.1002/art.10870

M. Weinblatt, M. Schiff, R. Valente, D. Van-der-heijde, G. Citera et al., Headtohead comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis : two-year efficacy and safety findings frome AMPLE trial, Annals of the Rheumatic Diseases, vol.2014, issue.73, pp.86-94

G. Burmester, A. Rubbert, A. Cantagrel, S. Hall, P. Leszczynski et al., A randomised, double-blind, parallelgroup study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study) Annals of the Rheumatic Diseases, p.1136, 2013.

F. Lanternier, F. Tubach, and P. Ravaud, Incidence and Risk Factors of Legionella pneumophila Pneumonia During Anti-Tumor Necrosis Factor Therapy, Chest, vol.144, issue.3, pp.990-998, 2013.
DOI : 10.1378/chest.12-2820

J. Listing, A. Strangfeld, and S. Kary, Infections in patients with rheumatoid arthritis treated with biologic agents, Arthritis & Rheumatism, vol.47, issue.11, pp.3403-3415, 2005.
DOI : 10.7326/0003-4819-130-6-199903160-00004

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.21386/pdf

Y. Lee, S. Bee, and G. Song, Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy, Clin Exp Rheumatol, vol.31, issue.1, pp.118-139, 2012.

P. Emery, F. Breedveld, and S. Hall, Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial, The Lancet, vol.372, issue.9636, pp.375-82, 2008.
DOI : 10.1016/S0140-6736(08)61000-4

L. Klareskog, D. Van-der-heijde, and J. De-jager, Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial, The Lancet, vol.363, issue.9410, pp.675-81, 2004.
DOI : 10.1016/S0140-6736(04)15640-7

I. Aubin-augier, A. Mercier, and L. Baumann, Introduction à la recherche qualitative, Exercer, vol.84, pp.142-147, 2008.

L. Marty, P. Vorilhon, and H. Vaillant-roussel, Recherche qualitative en médecine générale : expérimenter le focus group, Exercer, vol.98, pp.129-164, 2011.

A. Moreau, M. C. Dedianne, and L. Letrillart, et al, S'approprier la méthode du focus group. La revue du praticien en médecine générale, pp.382-386, 2004.

P. Touboul, Recherche qualitative. (En ligne) http://www.nice.cnge.fr

B. L. Combe, apport et les indications des biothérapies dans les rhumatismes inflammatoires, Bull Acad Natle Méd, vol.196, issue.7, pp.1279-1293, 2012.

M. Giraud, Coopération ville-hôpital : le point de vue des médecins généralistes, Thèse de médecine générale, 2010.

G. Hubert, La circulation de l'information médicale : évaluation du lien complexe ville-hôpital

M. Wattiaux, T. Lauret, and A. Macrez, Relations médecine de ville-hôpital, France, vol.516, pp.66-69, 2007.

P. Poindron, Carence de communication entre l'hôpital et la ville, Le concours médical, vol.128, pp.1148-1149, 2006.

P. François, D. Bertrand, G. Weil, and J. Bosson, Qualité des courriers de fin de séjour hospitalier : besoins et attentes des médecins libéraux, pp.1136-1139, 1996.

N. Lemaire, Evaluation qualitative de la relation ville-hôpital du point de vue des généralistes : données explicatives et ressenti face aux difficultés de communication, Thèse de médecine générale, 2016.

. L. Fabre, Communication ville-hôpital : qu'attendent les médecins généralistes de Midi- Pyrénées ? Thèse de médecine générale

A. Berendsen, A. Kuiken, W. Benneker, B. Jong, T. Voorn et al., How do general practitioners and specialists value their mutual communication? A survey, BMC Health Services Research, vol.76, issue.Suppl 1, p.143, 2009.
DOI : 10.1016/j.ijmedinf.2006.05.033

URL : https://bmchealthservres.biomedcentral.com/track/pdf/10.1186/1472-6963-9-143?site=bmchealthservres.biomedcentral.com

N. Hayaoui, Surveillance des patients atteints de rhumatisme inflammatoire chronique traités par biothérapie en médecine générale : enquête auprès des médecins généralistes de l'Hérault

J. Stross, Rheumatologists as an endangered species: A proposal for change, Arthritis & Rheumatism, vol.115, issue.6, pp.609-619, 1992.
DOI : 10.7326/0003-4819-115-9-715

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.1780350602/pdf

P. Helliwell, O. Hara, and M. , SHARED CARE BETWEEN HOSPITAL AND GENERAL PRACTICE: AN AUDIT OF DISEASE-MODIFYING DRUG MONITORING IN RHEUMATOID ARTHRITIS, Rheumatology, vol.34, issue.7, pp.673-679, 1995.
DOI : 10.1093/rheumatology/34.7.673

A. Rat, V. Henegariu, and M. Boissier, Do primary care physicians have a place in the management of rheumatoid arthritis ? Joint Bone Spine, pp.190-197, 2004.

M. Abolfotouh, M. Kamal, and M. El-bourgy, Quality of life and glycemic control in adolescents with type 1 diabetes and the impact of an education intervention, International Journal of General Medicine, vol.4, pp.141-52, 2011.
DOI : 10.2147/IJGM.S16951

N. Clark, C. Griffiths, and S. Keteyian, Educational and behavioral interventions for asthma : who achieves with outcomes ? A systematic review, Job Asthma and Allergy, vol.3, pp.187-97, 2010.

S. Kripalani, F. Lefevre, C. Phillips, M. Williams, P. Basaviah et al., Deficits in Communication and Information Transfer Between Hospital-Based and Primary Care Physicians, JAMA, vol.297, issue.8, pp.831-872, 2007.
DOI : 10.1001/jama.297.8.831

J. Keane, G. S. Wise, R. Mirabile-levens, E. Kasznica, J. Schwieterman et al., Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor ?????Neutralizing Agent, New England Journal of Medicine, vol.345, issue.15, pp.1098-104, 2001.
DOI : 10.1056/NEJMoa011110

L. Baronnet, T. Barnetche, V. Kahn, C. Lacoin, C. Richez et al., Incidence de la tuberculose chez les patients atteints de polyarthrite rhumato??de. Revue syst??matique de la litt??rature, Revue du Rhumatisme, vol.78, issue.2, pp.140-146, 2011.
DOI : 10.1016/j.rhum.2010.09.018